Not Yet RecruitingPhase 1ACTRN12605000783628

An Extension of the Written Disclosure Paradigm to the Psychotherapeutic Context: Can Systematic Changes in Emotion Regulation Strategy Reduce Distress and Improve Immune Function in Cancer Patients Living in Remission.

Evaluation of the Efficacy of Emotion Focused Psychotherapies for Reducing Distress and Improving Immune Function and Quality of Life in Cancer Patients Living in Remission.

Sponsor

The Cancer Centre, The Royal Adelaide Hospital

Enrollment

70 participants

Start Date

Jan 23, 2006

Study Type

Interventional

Conditions

Emotional Inhibition/Suppression Psychological Distress

Summary

Full ethical approval to proceed with the project has been given by all Institutions described above.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 74 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying An Extension of the Written Disclosure Paradigm to the Psychotherapeutic Context: Can Systematic Changes in Emotion Regulation Strategy Reduce Distress and Improve Immune Function in Cancer Patients Living in Remission.. You may be eligible if you are people aged 18 to 74 with received a diagnosis of stage i, or ii cancer (solid neoplasm) within the past 12 months. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

In the first of three studies that aim to the efficacy of psychotherapies focused on the expression of emotion, Pennebaker & Beal's (1986) written disclosure methodology will be applied to an individual psychotherapeutic context. In an extension of the Pennebaker & Beal (1986) paradigm; and in accord with recent theoretical developments (i.e., A to D Emotion Theory; Pennebaker & Chung (In-Press)), Participants allocated to the Treatment group will be encouraged to use emotion labels when expressing their deepest thoughts and feelings with respect to the following topics: Diagnosis (weeks 1 & 6); Treatment/Waiting for Results (weeks 2 & 7); Living in Remission (weeks 3 & 8); Most Distressing/Traumatic Experience (weeks 4 & 5). Participants randomly allocated to the Treatment group will attend 8 x 1 hour, individual sessions.